| EOS-AX4463 | Cisapride | 81098-60-4 | C23H29ClFN3O4 | 465.95 | COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F |
| EOS-AX4464 | Tandospirone | 87760-53-0 | C21H29N5O2 | 383.49 | O=C([C@@]1([H])[C@@](C([H])([H])C2([H])[H])([H])C([H])([H])[C@@]2([H])[C@]13[H])N(C([H])([H])C([H])([H])C([H])([H])C([H])([H])N4C([H])([H])C([H])([H])N(C5=NC([H])=C([H])C([H])=N5)C([H])([H])C4([H])[H])C3=O |
| EOS-AX4465 | PRX-08066 | 866206-54-4 | C19H17ClFN5S | 401.89 | C1CN(CCC1NC2=C3C=C(SC3=NC=N2)Cl)CC4=CC(=C(C=C4)F)C#N |
| EOS-AX4466 | Agomelatine hydrochloride | 1176316-99-6 | C15H18ClNO2 | 279.76 | C/C(O)=N/CCC1=CC=CC2=C1C=C(OC)C=C2.Cl |
| EOS-AX4467 | Agomelatine L(+)-Tartaric acid | 824393-18-2 | C19H23NO8 | 393.39 | C/C(O)=N/CCC1=CC=CC2=C1C=C(OC)C=C2.O[C@](C(O)=O)([H])[C@](O)([H])C(O)=O |
| EOS-AX4468 | Iloperidone hydrochloride | 1299470-39-5 | C24H28ClFN2O4 | 462.94 | CC(C1=CC(OC)=C(OCCCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C=C1)=O.Cl |
| EOS-AX4469 | Ondansetron hydrochloride dihydrate | 103639-04-9 | C18H24ClN3O3 | 365.85 | CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl |
| EOS-AX4470 | Fluvoxamine | 54739-18-3 | C15H21F3N2O2 | 318.33 | COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F |
| EOS-AX4471 | Pizotifen | 15574-96-6 | C19H21NS | 295.44 | CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1 |
| EOS-AX4472 | Zileuton sodium | 118569-21-4 | C11H11N2NaO2S | 258.27 | CC(N([O-])C(O)=N)C1=CC2=CC=CC=C2S1.[Na+] |
| EOS-AX4473 | Levalbuterol tartrate | 661464-94-4 | C30H48N2O12 | 628.71 | CC(C)(NC[C@@](O)([H])C1=CC(CO)=C(O)C=C1)C.CC(C)(NC[C@@](O)([H])C2=CC(CO)=C(O)C=C2)C.O[C@](C(O)=O)([H])[C@](O)([H])C(O)=O |
| EOS-AX4474 | Doxazosin | 74191-85-8 | C23H25N5O5 | 451.48 | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC |
| EOS-AX4475 | Aniracetam | 72432-10-1 | C12H13NO3 | 219.24 | COC1=CC=C(C=C1)C(=O)N2CCCC2=O |
| EOS-AX4476 | AICAR phosphate | 681006-28-0 | C9H17N4O9P | 356.23 | C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N.OP(=O)(O)O |
| EOS-AX4477 | Imeglimin | 775351-65-0 | C6H13N5 | 155.2 | CC1N=C(NC(=N1)N(C)C)N |
| EOS-AX4478 | AVE 0991 sodium salt | 306288-04-0 | C29H31N4NaO5S2 | 602.7 | CC/N=C([O-])/NS(C1=C(C2=CC=C(CN3C(C=O)=C(OC)N=C3C4=CC=CC=C4)C=C2)C=C(S1)CC(C)C)(=O)=O.[Na+] |
| EOS-AX4479 | Perindopril | 82834-16-0 | C19H32N2O5 | 368.47 | CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O |
| EOS-AX4480 | Gatifloxacin hydrochloride | 121577-32-0 | C19H23ClFN3O4 | 411.86 | CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl |
| EOS-AX4481 | Gatifloxacin mesylate | 316819-28-0 | C20H26FN3O7S | 471.5 | CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F.CS(=O)(=O)O |
| EOS-AX4482 | Meropenem trihydrate | 119478-56-7 | C17H31N3O8S | 437.51 | CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O |
| EOS-AX4483 | Moxifloxacin | 151096-09-2 | C21H24FN3O4 | 401.43 | COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O |
| EOS-AX4484 | Tigecycline hydrochloride | 197654-04-9 | C29H40ClN5O8 | 622.11 | CC(C)(NC/C(O)=N/C1=CC(N(C)C)=C(C2=C1O)C[C@@](C(C2=O)=C(O)[C@@]34O)([H])C[C@@]3([H])[C@@](N(C)C)([H])C(O)=C(C(O)=N)C4=O)C.Cl |
| EOS-AX4485 | Tigecycline mesylate | 1135871-27-0 | C30H43N5O11S | 681.75 | CC(C)(NC/C(O)=N/C1=CC(N(C)C)=C(C2=C1O)C[C@@](C(C2=O)=C(O)[C@@]34O)([H])C[C@@]3([H])[C@@](N(C)C)([H])C(O)=C(C(O)=N)C4=O)C.CS(O)(=O)=O |
| EOS-AX4486 | Norfloxacin hydrochloride | 68077-27-0 | C16H19ClFN3O3 | 355.79 | CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O.Cl |
| EOS-AX4487 | Pefloxacin | 70458-92-3 | C17H20FN3O3 | 333.36 | CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O |
| EOS-AX4488 | Vancomycin hydrochloride | 1404-93-9 | C66H76Cl3N9O24 | 1485.72 | |
| EOS-AX4489 | Anidulafungin | 166663-25-8 | C58H73N7O17 | 1140.24 | O[C@H]1[C@H](C)CN(C([C@H]([C@H](C)O)NC([C@H]([C@@H]([C@@H](C(C=C2)=CC=C2O)O)O)NC([C@H](C3)N(C([C@H]([C@H](C)O)NC4=O)=O)C[C@@H]3O)=O)=O)=O)[C@@H]1C(N[C@H]([C@@H](C[C@@H]4NC(C5=CC=C(C6=CC=C(C(C=C7)=CC=C7OCCCCC)C=C6)C=C5)=O)O)O)=O |
| EOS-AX4490 | Posaconazole hydrate | 1198769-38-8 | C37H44F2N8O5 | 718.79 | CC[C@@](N(N=CN1C2=CC=C(N3CCN(C4=CC=C(OC[C@@](CO5)([H])C[C@@]5(C6=C(F)C=C(F)C=C6)CN7C=NC=N7)C=C4)CC3)C=C2)C1=O)([H])[C@](O)([H])C.O |
| EOS-AX4491 | Fluconazole hydrate | 155347-36-7 | C13H14F2N6O2 | 324.29 | FC1=CC(F)=C(C(CN2C=NC=N2)(O)CN3C=NC=N3)C=C1.O |
| EOS-AX4492 | Fluconazole mesylate | 159532-41-9 | C14H16F2N6O4S | 402.38 | COC1=C(C23C[C@@]4([H])C[C@](C2)([H])C[C@](C3)([H])C4)C=C(C5=CC=C6C=C(C([O-])=O)C=CC6=C5)C=C1.[Na+] |
| EOS-AX4493 | PM00104 | 308359-57-1 | C37H38F3N3O8 | 709.71 | |
| EOS-AX4494 | Btk inhibitor 1 | 1412418-47-3 | C22H22N6O | 386.45 | NC1=C(C2=NC=N1)C(C3=CC=C(OC4=CC=CC=C4)C=C3)=NN2C5CCCNC5 |
| EOS-AX4495 | Gabapentin enacarbil | 478296-72-9 | C16H27NO6 | 329.39 | CC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O |
| EOS-AX4496 | Zonisamide sodium | 68291-98-5 | C8H7N2NaO3S | 234.21 | C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)[NH-].[Na+] |
| EOS-AX4497 | XL413 | 1169558-38-6 | C14H12ClN3O2 | 289.72 | C1CC(NC1)C2=NC(=O)C3=C(N2)C4=C(O3)C=CC(=C4)Cl |
| EOS-AX4498 | CDK4 inhibitor | 1256963-02-6 | C22H29ClN8 | 440.97 | CC(C)C1=C(C(=NN1)Cl)C2=NC(=NC=C2)NC3=NC=C(C=C3)N4CCC(CC4)N(C)C |
| EOS-AX4499 | WHI-P180 hydrochloride | 153437-55-9 | C16H16ClN3O3 | 333.77 | COC1=C(OC)C=C2C(C(NC3=CC(O)=CC=C3)=NC=N2)=C1.Cl |
| EOS-AX4500 | NVP 231 | 362003-83-6 | C25H25N3O2S | 431.55 | C1C2CC3CC1CC(C2)(C3)C(=O)NC4=CC5=C(C=C4)N=C(S5)NC(=O)C6=CC=CC=C6 |
| EOS-AX4501 | BML-277 | 516480-79-8 | C20H14ClN3O2 | 363.8 | C1=CC(=CC=C1C2=NC3=C(N2)C=C(C=C3)C(=O)N)OC4=CC=C(C=C4)Cl |
| EOS-AX4502 | LH846 | 639052-78-1 | C16H13ClN2OS | 316.81 | CC1=CC(S2)=C(N=C2/N=C(O)/CC3=CC=CC=C3)C=C1Cl |
| EOS-AX4503 | Cidofovir dihydrate | 149394-66-1 | C8H18N3O8P | 315.22 | C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O.O.O |
| EOS-AX4504 | Parecoxib Sodium | 198470-85-8 | C19H17N2NaO4S | 392.4 | CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+] |
| EOS-AX4505 | (+)-Ketoconazole | 142128-59-4 | C26H28Cl2N4O4 | 531.43 | CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl |
| EOS-AX4506 | Marbofloxacin hydrochloride | 115551-26-3 | C17H20ClFN4O4 | 398.82 | CN1CCN(C2=C(F)C=C(C(C(C(O)=O)=CN34)=O)C3=C2OCN4C)CC1.Cl |
| EOS-AX4507 | Haloperidol hydrochloride | 1511-16-6 | C21H24Cl2FNO2 | 412.33 | C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F.Cl |
| EOS-AX4508 | Amisulpride hydrochloride | 81342-13-4 | C17H28ClN3O4S | 405.94 | CCN1CCCC1C/N=C(O)/C2=CC(S(CC)(=O)=O)=C(N)C=C2OC.Cl |
| EOS-AX4509 | PYZD-4409 | 423148-78-1 | C14H7ClFN3O5 | 351.67 | C1=CC(=C(C=C1N2C(=O)C(=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N2)Cl)F |
| EOS-AX4510 | FAAH inhibitor 1 | 326866-17-5 | C24H23N3O3S3 | 497.65 | CC1=CC2=C(C=C1)N=C(S2)C3=CC=C(C=C3)NC(=O)C4CCN(CC4)S(=O)(=O)C5=CC=CS5 |
| EOS-AX4511 | Etomidate hydrochloride | 53188-20-8 | C14H17ClN2O2 | 280.75 | CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.Cl |
| EOS-AX4512 | Betamethasone hydrochloride | 956901-32-9 | C22H30ClFO5 | 428.92 | C[C@@]([C@]1(O)C(CO)=O)([H])C[C@@]([C@@]1(C[C@@](O)([H])[C@@]23F)C)([H])[C@]2([H])CCC4=CC(C=C[C@@]43C)=O.Cl |
| EOS-AX4513 | Beclomethasone dipropionate | 5534-09-8 | C28H37ClO7 | 521.04 | CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC |
| EOS-AX4514 | TDZD-8 | 327036-89-5 | C10H10N2O2S | 222.26 | CN1C(=O)N(C(=O)S1)CC2=CC=CC=C2 |
| EOS-AX4515 | Ezatiostat hydrochloride | 286942-97-0 | C27H36ClN3O6S | 566.11 | CCOC(=O)C(CCC(=O)NC(CSCC1=CC=CC=C1)C(=O)NC(C2=CC=CC=C2)C(=O)OCC)N.Cl |
| EOS-AX4516 | Valproic acid | 99-66-1 | C8H16O2 | 144.21 | CCCC(CCC)C(=O)O |
| EOS-AX4517 | Tenofovir hydrate | 206184-49-8 | C9H16N5O5P | 305.23 | CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O.O |
| EOS-AX4518 | Tenofovir maleate | 1236287-04-9 | C13H18N5O8P | 403.28 | C[C@](OCP(O)(O)=O)([H])CN1C=NC(C1=NC=N2)=C2N.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX4519 | Stavudine sodium | 134624-73-0 | C10H11N2NaO4 | 246.2 | CC(C(O)=NC1=O)=CN1[C@@]2([H])C=C[C@@](O2)([H])C[O-].[Na+] |
| EOS-AX4520 | AZ505 | 1035227-43-0 | C29H38Cl2N4O4 | 577.54 | C1CCC(CC1)N(CCNCCC2=C3C(=C(C=C2)O)NC(=O)CO3)C(=O)CCNCCC4=CC(=C(C=C4)Cl)Cl |
| EOS-AX4521 | AZ505 ditrifluoroacetate | 1035227-44-1 | C33H40Cl2F6N4O8 | 805.59 | ClC1=C(Cl)C=C(CCNCCC(N(C2CCCCC2)CCNCCC3=C4C(N=C(O)CO4)=C(O)C=C3)=O)C=C1.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O |
| EOS-AX4522 | TR-14035 | 232271-19-1 | C24H21Cl2NO5 | 474.33 | COC1=C(C(=CC=C1)OC)C2=CC=C(C=C2)CC(C(=O)O)NC(=O)C3=C(C=CC=C3Cl)Cl |
| EOS-AX4523 | (3S,4R)-Tofacitinib | 1092578-48-7 | C16H20N6O | 312.37 | CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N |
| EOS-AX4524 | (3R,4S)-Tofacitinib | 1092578-46-5 | C16H20N6O | 312.37 | CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N |
| EOS-AX4525 | CC-401 | 395104-30-0 | C22H24N6O | 388.47 | C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5 |
| EOS-AX4526 | Deltarasin hydrochloride | 1440898-82-7 | C40H38ClN5O | 640.22 | [H][C@@](C1CCNCC1)(N2C3=CC=CC=C3N=C2C4=CC=CC=C4)COC5=CC=C(C6=NC7=CC=CC=C7N6CC8=CC=CC=C8)C=C5.Cl |
| EOS-AX4527 | HG-10-102-01 | 1351758-81-0 | C17H20ClN5O3 | 377.83 | C/N=C(N1)\C(Cl)=CN=C1NC2=CC(OC)=C(C(N3CCOCC3)=O)C=C2 |
| EOS-AX4528 | CBB1007 | 1379573-92-8 | C27H34N8O4 | 534.61 | COC(C1=CC(CN2CCN(C(N)=N)CC2)=CC(C(N3CCN(C(C4=CC=C(C(N)=N)C=C4)=O)CC3)=O)=C1)=O |
| EOS-AX4529 | LXR-623 | 875787-07-8 | C21H12ClF5N2 | 422.78 | C1=CC2=C(N(N=C2C(=C1)C(F)(F)F)CC3=C(C=C(C=C3)F)Cl)C4=CC=C(C=C4)F |
| EOS-AX4530 | Biperiden | 514-65-8 | C21H29NO | 311.46 | C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O |
| EOS-AX4531 | Glycopyrrolate | 596-51-0 | C19H28BrNO3 | 398.33 | C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-] |
| EOS-AX4532 | Refametinib | 923032-37-5 | C19H20F3IN2O5S | 572.34 | COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F |
| EOS-AX4533 | NBI-98782 | 85081-18-1 | C19H29NO3 | 319.44 | CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1O)OC)OC |
| EOS-AX4534 | NBI-98854 | 171598-74-6 | C19H29NO3 | 319.44 | CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1O)OC)OC |
| EOS-AX4535 | Reserpine hydrochloride | 16994-56-2 | C33H41ClN2O9 | 645.14 | COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl |
| EOS-AX4536 | GNE-617 | 1362154-70-8 | C21H15F2N3O3S | 427.42 | FC1=CC(S(C2=CC=C(C=C2)CNC(C(C=C3)=CN4C3=NC=C4)=O)(=O)=O)=CC(F)=C1 |
| EOS-AX4537 | Fosaprepitant | 172673-20-0 | C23H22F7N4O6P | 614.41 | CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F |
| EOS-AX4538 | Flupirtine | 56995-20-1 | C15H17FN4O2 | 304.32 | CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N |
| EOS-AX4539 | AP20187 | 195514-80-8 | C82H107N5O20 | 1482.75 | O=C([C@@H]1CCCCN1C([C@@H](CC)C2=CC(OC)=C(OC)C(OC)=C2)=O)O[C@H](CCC3=CC(OC)=C(OC)C=C3)C4=CC=CC(OCC(NCC(CNC(COC5=CC=CC([C@@H](CCC6=CC(OC)=C(OC)C=C6)OC([C@H]7N(C([C@@H](CC)C8=CC(OC)=C(OC)C(OC)=C8)=O)CCCC7)=O)=C5)=O)CN(C)C)=O)=C4 |
| EOS-AX4540 | L-Thyroxine sodium salt pentahydrate | 6106-07-6 | C15H20I4NNaO9 | 888.93 | C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.O.O.O.O.O.[Na+] |
| EOS-AX4541 | Acarbose sulfate | 1221158-13-9 | C25H45NO22S | 743.68 | C[C@]1([H])[C@](N[C@@]2([H])C=C([C@](O)([H])[C@@](O)([H])[C@@]2([H])O)CO)([H])[C@@](O)([H])[C@](O)([H])[C@](O[C@]([C@@](O)([H])[C@](O)([H])[C@](O[C@]([C@@](O)([H])[C@](O)([H])[C@]3([H])O)([H])[C@@](O3)([H])CO)([H])O4)([H])[C@@]4([H])CO)([H])O1.OS(O)(=O)=O |
| EOS-AX4542 | Adapalene sodium salt | 911110-93-5 | C28H27NaO3 | 434.5 | COC1=C(C23C[C@@]4([H])C[C@](C2)([H])C[C@](C3)([H])C4)C=C(C5=CC=C6C=C(C([O-])=O)C=CC6=C5)C=C1.[Na+] |
| EOS-AX4543 | Benazepril | 86541-75-5 | C24H28N2O5 | 424.49 | CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O |
| EOS-AX4544 | Dorzolamide | 120279-96-1 | C10H16N2O4S3 | 324.44 | CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C |
| EOS-AX4545 | Prilocaine hydrochloride | 1786-81-8 | C13H21ClN2O | 256.77 | CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl |
| EOS-AX4546 | SB-334867 | 249889-64-3 | C17H14ClN5O2 | 355.78 | CC1=NC2=C(O1)C=C(C=C2)NC(=O)NC3=C4C(=NC=C3)C=CC=N4 |
| EOS-AX4547 | A 839977 | 870061-27-1 | C19H14Cl2N6O | 413.26 | ClC1=C(Cl)C(N2/C(N=NN2)=N\CC3=CC=CC=C3OC4=CC=CC=N4)=CC=C1 |
| EOS-AX4548 | Prasugrel hydrochloride | 389574-19-0 | C20H21ClFNO3S | 409.9 | CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl |
| EOS-AX4549 | Prasugrel Maleic acid | 389574-20-3 | C24H24FNO7S | 489.51 | CC(OC1=CC2=C(S1)CCN(C(C(C3CC3)=O)C4=CC=CC=C4F)C2)=O.O=C(O)/C([H])=C([H])\C(O)=O |
| EOS-AX4550 | SB 203580 hydrochloride | 869185-85-3 | C21H17ClFN3OS | 413.9 | |
| EOS-AX4551 | AZD7545 | 252017-04-2 | C19H18ClF3N2O5S | 478.87 | CC(C(=O)NC1=C(C=C(C=C1)S(=O)(=O)C2=CC=C(C=C2)C(=O)N(C)C)Cl)(C(F)(F)F)O |
| EOS-AX4552 | Ro 31-8220 | 125314-64-9 | C25H23N5O2S | 457.55 | CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)CCCSC(=N)N |
| EOS-AX4553 | Rigosertib | 592542-59-1 | C21H25NO8S | 451.49 | COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)O |
| EOS-AX4554 | Minoxidil | 38304-91-5 | C9H15N5O | 209.25 | C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O |
| EOS-AX4555 | Lansoprazole sodium | 226904-00-3 | C16H13F3N3NaO2S | 391.34 | CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+] |
| EOS-AX4556 | Acitretin sodium | 925701-88-8 | C21H25NaO3 | 348.41 | CC(/C([H])=C([H])/C1=C(C=C(OC)C(C)=C1C)C)=C([H])\C([H])=C([H])\C(C)=C([H])\C([O-])=O.[Na+] |
| EOS-AX4557 | Delavirdine | 136817-59-9 | C22H28N6O3S | 456.56 | CC(C)NC1=C(N=CC=C1)N2CCN(CC2)C(=O)C3=CC4=C(N3)C=CC(=C4)NS(=O)(=O)C |
| EOS-AX4558 | Y-27632 | 146986-50-7 | C14H21N3O | 247.34 | CC(C1CCC(CC1)C(=O)NC2=CC=NC=C2)N |
| EOS-AX4559 | SR-3677 | 1072959-67-1 | C22H24N4O4 | 408.45 | CN(C)CCOC1=C(C=CC(=C1)C2=CNN=C2)NC(=O)C3COC4=CC=CC=C4O3 |
| EOS-AX4560 | BIX 02565 | 1311367-27-7 | C26H30N6O2 | 458.56 | C[C@](N12)([H])CCNC(C2=CC3=C1C=C(/C(O)=N/C4=NC5=CC=CC=C5N4CCCN(C)C)C=C3)=O |
| EOS-AX4561 | Glibenclamide | 10238-21-8 | C23H28ClN3O5S | 494 | COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3 |
| EOS-AX4562 | Siramesine | 147817-50-3 | C30H31FN2O | 454.58 | C1CN(CCC12C3=CC=CC=C3CO2)CCCCC4=CN(C5=CC=CC=C54)C6=CC=C(C=C6)F |
| EOS-AX4563 | K145 | 1309444-75-4 | C18H24N2O3S | 348.46 | CCCCOC1=CC=C(C=C1)CC/C([H])=C(S2)/C(N(C2=O)CCN)=O |
| EOS-AX4564 | 1-NM-PP1 | 221244-14-0 | C20H21N5 | 331.41 | CC(C)(C)N1C2=C(C(=N1)CC3=CC=CC4=CC=CC=C43)C(=NC=N2)N |
| EOS-AX4565 | A 419259 | 364042-47-7 | C29H34N6O | 482.62 | CN1CCN([C@@]2([H])CC[C@@](N3C=C(C(C3=NC=N4)=C4N)C5=CC=C(OC6=CC=CC=C6)C=C5)([H])CC2)CC1 |
| EOS-AX4566 | A 419259 trihydrochloride | 1435934-25-0 | C29H37Cl3N6O | 592 | CN1CCN([C@@]2([H])CC[C@@](N3C=C(C(C3=NC=N4)=C4N)C5=CC=C(OC6=CC=CC=C6)C=C5)([H])CC2)CC1.Cl.Cl.Cl |
| EOS-AX4567 | Amsacrine | 51264-14-3 | C21H19N3O3S | 393.46 | COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42 |
| EOS-AX4568 | Amsacrine hydrochloride | 54301-15-4 | C21H20ClN3O3S | 429.92 | COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42.Cl |
| EOS-AX4569 | Palosuran | 540769-28-6 | C25H30N4O2 | 418.53 | CC1=NC2=CC=CC=C2C(=C1)NC(=O)NCCN3CCC(CC3)(CC4=CC=CC=C4)O |
| EOS-AX4570 | SKLB1002 | 1225451-84-2 | C13H12N4O2S2 | 320.39 | CC1=NN=C(S1)SC2=NC=NC3=CC(=C(C=C32)OC)OC |
| EOS-AX4571 | KN-93 hydrochloride | 1956426-56-4 | C26H30Cl2N2O4S | 537.5 | CN(CC1=CC=CC=C1N(S(C2=CC=C(OC)C=C2)(=O)=O)CCO)C/C([H])=C([H])/C3=CC=C(Cl)C=C3.Cl |
| EOS-AX4572 | SJB3-019A | | C16H8N2O3 | 276.25 | O=C(C1=C2OC(C3=CN=CC=C3)=N1)C4=CC=CC=C4C2=O |
| EOS-AX4573 | OTSSP167 hydrochloride | 1431698-10-0 | C25H29Cl3N4O2 | 523.88 | CC(=O)C1=CN=C2C=CC(=C3C=C(C(=O)C(=C3)Cl)Cl)NC2=C1NC4CCC(CC4)CN(C)C.Cl |
| EOS-AX4574 | GNE-617 hydrochloride | | C21H16ClF2N3O3S | 463.88 | FC1=CC(F)=CC(S(C2=CC=C(C/N=C(O)/C3=CN4C=CN=C4C=C3)C=C2)(=O)=O)=C1.Cl |
| EOS-AX4575 | DL-threo-2-methylisocitrate sodium | | C14H14Na6O14 | 544.19 | C[C@](C([O-])=O)(O)[C@@](C([O-])=O)([H])CC([O-])=O.C[C@](C([O-])=O)(O)[C@@](C([O-])=O)([H])CC([O-])=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] |
| EOS-AX4576 | A-317491 sodium salt hydrate | | C33H29NNaO9+ | 606.57 | C1CC(C2=CC=CC=C2C1)N(CC3=CC(=CC=C3)OC4=CC=CC=C4)C(=O)C5=CC(=C(C=C5C(=O)O)C(=O)O)C(=O)O.O.[Na+] |
| EOS-AX4577 | Doxercalciferol-D3 | | C28H44O2 | 415.67 | CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C |
| EOS-AX4578 | Maxacalcitol-D6 | | C26H42O4 | 424.65 | CC(C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)OCCC(C)(C)O |
| EOS-AX4579 | Alfacalcidol-D6 | | C27H44O2 | 406.67 | CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C |
| EOS-AX4580 | Paricalcitol-D6 | | C27H44O3 | 422.67 | CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C |
| EOS-AX4581 | Calcitriol Derivatives | | C30H47NO3 | 469.7 | CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)OCCC#N)C |
| EOS-AX4582 | ML-323 | 1572414-83-5 | C23H24N6 | 384.48 | CC(C1=CC=CC=C1C2=NC=C(/C(N2)=N\CC3=CC=C(N4C=CN=N4)C=C3)C)C |
| EOS-AX4583 | YS-49 monohydrate | 132836-42-1 | C20H22BrNO3 | 404.3 | OC1=C(O)C=C2C(CCNC2CC3=CC=CC4=CC=CC=C43)=C1.Br.O |
| EOS-AX4584 | Cys-mcMMAD | | C54H84N8O11S2 | 1085.42 | CC[C@]([C@@](N(C([C@](/N=C(O)/[C@](N(C(CCCCCN1C(CC(SC[C@@](N)([H])C(O)=O)([H])C1=O)=O)=O)C)([H])C(C)C)([H])C(C)C)=O)C)([H])[C@@](OC)([H])CC(N2CCC[C@@]2([H])[C@@](OC)([H])[C@@](/C(O)=N/[C@@](C3=NC=CS3)([H])CC4=CC=CC=C4)([H])C)=O)([H])C |
| EOS-AX4585 | OTSSP167 | 1431697-89-0 | C25H28Cl2N4O2 | 487.42 | CC(=O)C1=CN=C2C=CC(=C3C=C(C(=O)C(=C3)Cl)Cl)NC2=C1NC4CCC(CC4)CN(C)C |
| EOS-AX4586 | Dye 993 | | C34H42IN5S | 679.7 | CN(CCC/[N+](CCCN(C)C)=C1C=C(C2=CC=CC=C2N/1C3=CC=CC=C3)/C=C4N(C5=CC=CC=C5S\4)C)C.[I-] |
| EOS-AX4587 | (R)-Nepicastat HCl | 195881-94-8 | C14H15F2N3S.HCl | 331.81 | C1CC2=C(C=C(C=C2CC1N3C(=CNC3=S)CN)F)F.Cl |
| EOS-AX4588 | CGS 21680 HCl | 124431-80-7 | C23H30ClN7O6 | 535.98 | CCNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3N)NCCC4=CC=C(C=C4)CCC(=O)O)O)O.Cl |
| EOS-AX4589 | EUK 134 | 81065-76-1 | C18H18ClMnN2O4 | 416.74 | COC1=CC=CC(=C1[O-])C=NCCN=CC2=C(C(=CC=C2)OC)[O-].[Cl-].[Mn+2] |
| EOS-AX4590 | DL-Adrenaline | 329-65-7 | C9H13NO3 | 183.2 | CNCC(C1=CC(=C(C=C1)O)O)O |
| EOS-AX4591 | Epinephrine HCl | 55-31-2 | C9H13NO3.HCl | 219.67 | CNCC(C1=CC(=C(C=C1)O)O)O.Cl |
| EOS-AX4592 | Terbutaline Sulfate | 23031-32-5 | C24H38N2O6.H2O4S | 548.65 | CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O |
| EOS-AX4593 | Tolazoline HCl | 59-97-2 | C10H12N2.HCl | 196.68 | C1CN=C(N1)CC2=CC=CC=C2.Cl |
| EOS-AX4594 | Acebutolol HCl | 34381-68-5 | C18H28N2O4.HCl | 372.89 | CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl |
| EOS-AX4595 | Adrenalone HCl | 62-13-5 | C9H11NO3.HCl | 217.65 | CNCC(=O)C1=CC(=C(C=C1)O)O.Cl |
| EOS-AX4596 | Carvedilol | 72956-09-3 | C24H26N2O4 | 406.47 | COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O |
| EOS-AX4597 | Clonidine HCl | 4205-91-8 | C9H9Cl2N3.HCl | 266.5 | C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl |
| EOS-AX4598 | Dexmedetomidine | 113775-47-6 | C13H16N2 | 200.28 | CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C |
| EOS-AX4599 | Guanabenz Acetate | 23256-50-0 | C8H8Cl2N4.C2H4O2 | 291.13 | CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl |
| EOS-AX4600 | Isoprenaline HCl | 51-30-9 | C11H17NO3.HCl | 247.72 | CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl |
| EOS-AX4601 | L-Adrenaline | 51-43-4 | C9H13NO3 | 183.2 | CNCC(C1=CC(=C(C=C1)O)O)O |
| EOS-AX4602 | Maprotiline HCl | 10347-81-6 | C20H23N.HCl | 313.86 | Cl[H].[H]C12C([H])([H])C([H])([H])C(C3=C([H])C([H])=C([H])C([H])=C23)(C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14 |
| EOS-AX4603 | Metoprolol Tartrate | 56392-17-7 | 2C15H25NO3.C4H6O6 | 684.81 | CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4604 | Naphazoline HCl | 550-99-2 | C14H14N2.HCl | 246.74 | C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl |
| EOS-AX4605 | Nebivolol | 152520-56-4 | C22H26ClF2NO4 | 441.9 | C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl |
| EOS-AX4606 | Oxymetazoline HCl | 2315-02-8 | C16H24N2O.HCl | 296.84 | CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl |
| EOS-AX4607 | Phenoxybenzamine HCl | 63-92-3 | C18H22ClNO.HCl | 340.3 | CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl |
| EOS-AX4608 | Phenylephrine HCl | 61-76-7 | C9H13NO2.HCl | 203.67 | CNCC(C1=CC(=CC=C1)O)O.Cl |
| EOS-AX4609 | Propranolol HCl | 318-98-9 | C16H21NO2.HCl | 295.8 | CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl |
| EOS-AX4610 | Ritodrine HCl | 23239-51-2 | C17H21NO3.HCl | 323.81 | CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl |
| EOS-AX4611 | Salbutamol Sulfate | 51022-70-9 | C13H21NO3.H2SO4 | 337.39 | CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O |
| EOS-AX4612 | Tetrahydrozoline HCl | 522-48-5 | C13H16N2.HCl | 236.74 | C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl |
| EOS-AX4613 | Timolol Maleate | 26921-17-5 | C17H28N4O7S | 432.49 | CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O |
| EOS-AX4614 | Xylazine HCl | 23076-35-9 | C12H16N2S.HCl | 256.79 | CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl |
| EOS-AX4615 | Betaxolol | 659-18-7 | C18H29NO3 | 307.43 | B(OCC(F)(F)F)(OCC(F)(F)F)OCC(F)(F)F |
| EOS-AX4616 | Betaxolol HCl | 63659-19-8 | C18H29NO3.HCl | 343.89 | CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl |
| EOS-AX4617 | Bisoprolol fumarate | 104344-23-2 | C22H35NO8 | 441.52 | CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O |
| EOS-AX4618 | Cisatracurium Besylate | 96946-42-8 | C53H72N2O12.2C6H5O3S | 1243.48 | C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-] |
| EOS-AX4619 | Detomidine HCl | 90038-01-0 | C12H15ClN2 | 222.71 | CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl |
| EOS-AX4620 | Dexmedetomidine HCl | 145108-58-3 | C13H16N2.HCl | 236.74 | CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl |
| EOS-AX4621 | Epinephrine Bitartrate | 51-42-3 | C9H13NO3.C4H6O6 | 333.29 | CNCC(C1=CC(=C(C=C1)O)O)O.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4622 | Formoterol Hemifumarate | 43229-80-7 | C42H52N4O12 | 804.88 | CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.CC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O |
| EOS-AX4623 | Ivabradine HCl | 148849-67-6 | C27H37ClN2O5 | 505.05 | CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl |
| EOS-AX4624 | Medetomidine HCl | 86347-15-1 | C13H16N2.HCl | 236.74 | CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl |
| EOS-AX4625 | Naftopidil | 57149-07-2 | C24H28N2O3 | 392.49 | COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O |
| EOS-AX4626 | Phentolamine Mesylate | 65-28-1 | C17H19N3O.CH4O3S | 377.46 | CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O |
| EOS-AX4627 | Scopine | 498-45-3 | C8H13NO2 | 155.19 | [H][C@]12O[C@@]1([H])[C@@](C3([H])[H])([H])N(C([H])([H])[H])[C@]2([H])C([H])([H])[C@@]3([H])O[H] |
| EOS-AX4628 | Terazosin HCl | 70024-40-7 | C19H25N5O4.HCl.2H2O | 459.92 | COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl |
| EOS-AX4629 | Naftopidil DiHCl | 57149-08-3 | C24H28N2O3.2HCl | 465.41 | COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O.Cl.Cl |
| EOS-AX4630 | Sotalol | 3930-20-9 | C12H20N2O3S.HCl | 308.82 | CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl |
| EOS-AX4631 | Tizanidine HCl | 64461-82-1 | C9H9Cl2N5S | 290.17 | C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl |
| EOS-AX4632 | Indacaterol Maleate | 753498-25-8 | C24H28N2O3.C4H4O4 | 508.56 | CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O |
| EOS-AX4633 | Synephrine HCl | 5985-28-4 | C9H13NO2.HCl | 203.67 | CNCC(C1=CC=C(C=C1)O)O.Cl |
| EOS-AX4634 | Miltefosine | 58066-85-6 | C21H46NO4P | 407.57 | CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C |
| EOS-AX4635 | Dorsomorphin 2HCl | 1219168-18-9 | C24H25N5O.2HCl | 472.41 | C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3.Cl.Cl |
| EOS-AX4636 | Phenformin HCl | 834-28-6 | C10H16ClN5 | 241.72 | C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl |
| EOS-AX4637 | WZ4003 | 1214265-58-3 | C25H29ClN6O3 | 496.99 | CCC(=O)NC1=CC(=CC=C1)OC2=NC(=NC=C2Cl)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC |
| EOS-AX4638 | Dehydroepiandrosterone (DHEA) | 53-43-0 | C19H28O2 | 288.42 | CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C |
| EOS-AX4639 | Flutamide | 13311-84-7 | C11H11F3N2O3 | 276.21 | CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F |
| EOS-AX4640 | Megestrol Acetate | 595-33-5 | C24H32O4 | 384.51 | CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C |
| EOS-AX4641 | Spironolactone | 52-01-7 | C24H32O4S | 416.57 | CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C |
| EOS-AX4642 | TAME | 901-47-3 | C14H22N4O4S | 342.41 | CC1=CC=C(C=C1)S(=O)(=O)NC(CCCN=C(N)N)C(=O)OC |
| EOS-AX4643 | Aminoglutethimide | 125-84-8 | C13H16N2O2 | 232.28 | CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N |
| EOS-AX4644 | Formestane | 566-48-3 | C19H26O3 | 302.41 | CC12CCC(=O)C(=C1CCC3C2CCC4(C3CCC4=O)C)O |
| EOS-AX4645 | Anastrozole | 120511-73-1 | C17H19N5 | 293.37 | CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N |
| EOS-AX4646 | VE-822 | 1232416-25-9 | C24H25N5O3S | 463.55 | CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N |
| EOS-AX4647 | Ciclopirox ethanolamine | 41621-49-2 | C12H17NO2.C2H7NO | 268.35 | CC1=CC(=O)N(C(=C1)C2CCCCC2)O.C(CO)N |
| EOS-AX4648 | Golgicide A | 1139889-93-2 | C17H14F2N2 | 284.3 | C1C=CC2C1C(NC3=C(C=C(C=C23)F)F)C4=CN=CC=C4 |
| EOS-AX4649 | Milrinone | 78415-72-2 | C12H9N3O | 211.22 | CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2 |
| EOS-AX4650 | (-)-Blebbistatin | 856925-71-8 | C18H16N2O2 | 292.33 | O[C@@]12CCN(C3=CC=CC=C3)C1=NC4=CC=C(C)C=C4C2=O |
| EOS-AX4651 | Esomeprazole Sodium | 161796-78-7 | C17H18N3NaO3S | 367.4 | CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+] |
| EOS-AX4652 | Amiodarone HCl | 19774-82-4 | C25H30ClI2NO3 | 681.77 | CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl |
| EOS-AX4653 | Carbamazepine | 298-46-4 | C15H12N2O | 236.27 | C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N |
| EOS-AX4654 | Divalproex Sodium | 76584-70-8 | C8H16O2.C8H15O2.Na | 310.41 | CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+] |
| EOS-AX4655 | Loperamide HCl | 34552-83-5 | C29H33ClN2O2.HCl | 513.5 | |
| EOS-AX4656 | Nitrendipine | 39562-70-4 | C18H20N2O6 | 360.3699 | CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C |
| EOS-AX4657 | Tamoxifen Citrate | 54965-24-1 | C32H37NO8 | 563.64 | CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4658 | Sulfacetamide Sodium | 127-56-0 | C8H10N2O3S.Na | 236.22 | CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+] |
| EOS-AX4659 | Trifluoperazine 2HCl | 440-17-5 | C21H24F3N3S.2HCl | 480.42 | CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl |
| EOS-AX4660 | Azithromycin | 83905-01-5 | C38H72N2O12 | 748.98 | CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O |
| EOS-AX4661 | Temozolomide | 85622-93-1 | C6H6N6O2 | 194.15 | CN1C(=O)N2C=NC(=C2N=N1)C(=O)N |
| EOS-AX4662 | Brefeldin A | 20350-15-6 | C16H24O4 | 280.36 | CC1CCCC=CC2CC(CC2C(C=CC(=O)O1)O)O |
| EOS-AX4663 | Cabozantinib malate (XL184) | 1140909-48-3 | C32H30FN3O10 | 635.59 | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O |
| EOS-AX4664 | GZD824 | 1421783-64-3 | C29H27F3N6O.2CH4O3S | 724.77 | CC1=CC=C(C(NC2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)=O)C=C1C#CC4=CN=C5C(C=NN5)=C4.CS(=O)(O)=O.CS(=O)(O)=O |
| EOS-AX4665 | Bafetinib (INNO-406) | | | | |
| EOS-AX4666 | DCC-2036 (Rebastinib) | 1020172-07-9 | C30H28FN7O3 | 553.59 | CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5 |
| EOS-AX4667 | GW5074 | 220904-83-6 | C15H8Br2INO2 | 520.95 | C1=CC2=C(C=C1I)C(=CC3=CC(=C(C(=C3)Br)O)Br)C(=O)N2 |
| EOS-AX4668 | SB590885 | 405554-55-4 | C27H27N5O2 | 453.55 | CN(C)CCOC1=CC=C(C=C1)C2=NC(=C3C=CC4=C(CCC4=C3)N=O)C(=C5C=CNC=C5)N2 |
| EOS-AX4669 | Dabrafenib (GSK2118436) | 1195765-45-7 | C23H20F3N5O2S2 | 519.56 | CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F |
| EOS-AX4670 | CNX-774 | 1202759-32-7 | C26H22FN7O3 | 499.5 | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)F |
| EOS-AX4671 | Benidipine HCl | 91599-74-5 | C28H31N3O6.HCl | 542.02 | CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl |
| EOS-AX4672 | Amlodipine | 88150-42-9 | C20H25ClN2O5 | 408.88 | CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN |
| EOS-AX4673 | Amlodipine Besylate | 111470-99-6 | C20H25ClN2O5.C6H6O3S | 567.05 | CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O |
| EOS-AX4674 | Flunarizine 2HCl | 30484-77-6 | C26H26F2N2.2HCl | 477.42 | C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl |
| EOS-AX4675 | Tetracaine HCl | 136-47-0 | C15H24N2O2.HCl | 300.82 | CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl |
| EOS-AX4676 | Azelnidipine | 123524-52-7 | C33H34N4O6 | 582.65 | CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C |
| EOS-AX4677 | Clevidipine Butyrate | 167221-71-8 | C21H23Cl2NO6 | 456.32 | CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C |
| EOS-AX4678 | Felodipine | 72509-76-3 | C18H19Cl2NO4 | 384.25 | CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C |
| EOS-AX4679 | Lacidipine | 103890-78-4 | C26H33NO6 | 455.54 | CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C |
| EOS-AX4680 | Manidipine | 89226-50-6 | C35H38N4O6 | 610.7 | CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC |
| EOS-AX4681 | Manidipine 2HCl | 89226-75-5 | C35H40Cl2N4O6 | 683.62 | CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl |
| EOS-AX4682 | Bupivacaine HCl | 18010-40-7 | C18H28N2O.HCl | 324.89 | CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl |
| EOS-AX4683 | Forskolin | 66575-29-9 | C22H34O7 | 410.5 | CC(=O)OC1C(C2C(CCC(C2(C3(C1(OC(CC3=O)(C)C=C)C)O)C)O)(C)C)O |
| EOS-AX4684 | Tasisulam | 519055-62-0 | C11H6BrCl2NO3S2 | 415.11 | C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br |
| EOS-AX4685 | Cinacalcet HCl | 364782-34-3 | C22H23ClF3N | 393.87 | CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl |
| EOS-AX4686 | NPS-2143 | 284035-33-2 | C24H25ClN2O2 | 408.93 | CC(C)(CC1=CC2=CC=CC=C2C=C1)NCC(COC3=C(C(=CC=C3)Cl)C#N)O |
| EOS-AX4687 | BML-190 | 2854-32-2 | C23H23ClN2O4 | 426.89 | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)N4CCOCC4 |
| EOS-AX4688 | Org 27569 | 868273-06-7 | C24H28ClN3O | 409.95 | CCC1=C(NC2=C1C=C(C=C2)Cl)C(=O)NCCC3=CC=C(C=C3)N4CCCCC4 |
| EOS-AX4689 | AM251 | 183232-66-8 | C22H21Cl2IN4O | 555.24 | CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)I |
| EOS-AX4690 | GW842166X | 666260-75-9 | C18H17Cl2F3N4O2 | 449.25 | C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl |
| EOS-AX4691 | Rimonabant | 168273-06-1 | C22H21Cl3N4O | 463.79 | CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl |
| EOS-AX4692 | P276-00 | 920113-03-7 | C21H20ClNO5.HCl | 438.3 | CN1CCC(C1CO)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O.Cl |
| EOS-AX4693 | TG003 | 300801-52-9 | C13H15NO2S | 249.33 | CCN1C2=C(C=CC(=C2)OC)SC1=CC(=O)C |
| EOS-AX4694 | HIV-1 Tat Protein Peptide | 191936-91-1 | C64H118N32O14 | 1559.83 | C1=CC(=CC=C1CC(C(=O)NCC(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(CCCCN)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)O)N)O |
| EOS-AX4695 | NGR peptide | 651328-78-8 | C20H36N10O8S2 | 608.69 | C(CC(C(=O)NC(CS)C(=O)NCC(=O)O)NC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CS)N)CN=C(N)N |
| EOS-AX4696 | CFTRinh-172 | 307510-92-5 | C18H10F3NO3S2 | 409.4 | C1=CC(=CC(=C1)N2C(=O)C(=CC3=CC=C(C=C3)C(=O)O)SC2=S)C(F)(F)F |
| EOS-AX4697 | MK-3207 HCl | 957116-20-0 | C31H30ClF2N5O3 | 594.05 | C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4.Cl |
| EOS-AX4698 | PF-477736 | 952021-60-2 | C22H25N7O2 | 419.48 | O=C(C(C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H])([H])N([H])[H])N([H])C2=C([H])C3=C4C(N=C(C5=C([H])N(C([H])([H])[H])N=C5[H])C4=C([H])N([H])N([H])C3=O)=C2[H] |
| EOS-AX4699 | BMS-794833 | 1174046-72-0 | C23H15ClF2N4O3 | 468.84 | C1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F |
| EOS-AX4700 | Golvatinib (E7050) | 928037-13-2 | C33H37F2N7O4 | 633.69 | CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F |
| EOS-AX4701 | Acemetacin | 53164-05-9 | C21H18ClNO6 | 415.82 | CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O |
| EOS-AX4702 | Lornoxicam | 70374-39-9 | C13H10ClN3O4S2 | 371.82 | CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3 |
| EOS-AX4703 | Ampiroxicam | 99464-64-9 | C20H21N3O7S | 447.46 | CCOC(=O)OC(C)OC1=C(N(S(=O)(=O)C2=CC=CC=C21)C)C(=O)NC3=CC=CC=N3 |
| EOS-AX4704 | Bufexamac | 2438-72-4 | C12H17NO3 | 223.27 | CCCCOC1=CC=C(C=C1)CC(=O)NO |
| EOS-AX4705 | Etodolac | 41340-25-4 | C17H21NO3 | 287.35 | CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O |
| EOS-AX4706 | Flunixin Meglumin | 42461-84-7 | C14H11F3N2O2.C7H17NO5 | 491.46 | CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O |
| EOS-AX4707 | Ketoprofen | 22071-15-4 | C16H14O3 | 254.28 | CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O |
| EOS-AX4708 | Ketorolac tromethamine salt | 74103-07-4 | C19H24N2O6 | 376.4 | C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O |
| EOS-AX4709 | Licofelone | 156897-06-2 | C23H22ClNO2 | 379.88 | CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C |
| EOS-AX4710 | Mefenamic Acid | 61-68-7 | C15H15NO2 | 241.29 | CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C |
| EOS-AX4711 | Nabumetone | 42924-53-8 | C15H16O2 | 228.29 | CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC |
| EOS-AX4712 | Nimesulide | 51803-78-2 | C13H12N2O5S | 308.31 | CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2 |
| EOS-AX4713 | Phenacetin | 62-44-2 | C10H13NO2 | 179.22 | CCOC1=CC=C(C=C1)NC(=O)C |
| EOS-AX4714 | Rofecoxib | 162011-90-7 | C17H14O4S | 314.36 | CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3 |
| EOS-AX4715 | Tolfenamic Acid | 13710-19-5 | C14H12ClNO2 | 261.7 | CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O |
| EOS-AX4716 | Asaraldehyde | 4460-86-0 | C10H12O4 | 196.2 | COC1=CC(=C(C=C1C=O)OC)OC |
| EOS-AX4717 | Diclofenac Sodium | 15307-79-6 | C14H10Cl2NNaO2 | 318.13 | C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+] |
| EOS-AX4718 | Lumiracoxib | 220991-20-8 | C15H13ClFNO2 | 293.72 | CC1=CC(=C(C=C1)NC2=C(C=CC=C2Cl)F)CC(=O)O |
| EOS-AX4719 | Valdecoxib | 181695-72-7 | C16H14N2O3S | 314.36 | CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N |
| EOS-AX4720 | Zaltoprofen | 74711-43-6 | C17H14O3S | 298.36 | CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O |
| EOS-AX4721 | Triflusal | 322-79-2 | C10H7F3O4 | 248.16 | CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O |
| EOS-AX4722 | KPT-185 | 1333151-73-7 | C16H16F3N3O3 | 355.31 | CC(C)OC(=O)C=CN1C=NC(=N1)C2=CC(=CC(=C2)OC)C(F)(F)F |
| EOS-AX4723 | KPT-276 | 1421919-75-6 | C16H10F8N4O | 426.26 | C1C(CN1C(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)(F)F |
| EOS-AX4724 | KPT-330 | 1393477-72-9 | C17H11F6N7O | 443.31 | C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F |
| EOS-AX4725 | Plerixafor 8HCl (AMD3100 8HCl) | 155148-31-5 | C28H62Cl8N8 | 794.47 | C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl |
| EOS-AX4726 | WZ811 | 55778-02-4 | C18H18N4 | 290.36 | C1=CC=NC(=C1)NCC2=CC=C(C=C2)CNC3=CC=CC=N3 |
| EOS-AX4727 | TCID | 30675-13-9 | C9H2Cl4O2 | 283.92 | C1C(=O)C2=C(C1=O)C(=C(C(=C2Cl)Cl)Cl)Cl |
| EOS-AX4728 | Adenine | 73-24-5 | C5H5N5 | 135.13 | C1=NC2=C(N1)C(=NC=N2)N |
| EOS-AX4729 | Adenine sulfate | 321-30-2 | 2(C5H5N5).H2SO4 | 368.33 | C1=NC2=C(N1)C(=NC=N2)N.C1=NC2=C(N1)C(=NC=N2)N.OS(=O)(=O)O |
| EOS-AX4730 | Procarbazine HCl | 366-70-1 | C12H19N3O.HCl | 257.76 | CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl |
| EOS-AX4731 | Adenine HCl | 2922-28-3 | C5H5N5.HCl | 171.59 | C1=NC2=C(N1)C(=NC=N2)N.Cl |
| EOS-AX4732 | Mizoribine | 50924-49-7 | C9H13N3O6 | 259.22 | C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N |
| EOS-AX4733 | Uridine | 58-96-8 | C9H12N2O6 | 244.2 | C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O |
| EOS-AX4734 | FT-207 (NSC 148958) | 17902-23-7 | C8H9FN2O3 | 200.17 | C1CC(OC1)N2C=C(C(=O)NC2=O)F |
| EOS-AX4735 | Flupirtine maleate | 75507-68-5 | C19H21FN4O6 | 420.39 | CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O |
| EOS-AX4736 | Raltitrexed | 112887-68-0 | C21H22N4O6S | 458.49 | CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O |
| EOS-AX4737 | Lurasidone HCl | 367514-88-3 | C28H37ClN4O2S | 529.14 | Cl[H].O=C(C1([H])[C@](C([H])([H])C2([H])[H])([H])C([H])([H])C2([H])C13[H])N(C([H])([H])C4([H])C(C([H])([H])N5C([H])([H])C([H])([H])N(C6=NSC7=C6C([H])=C([H])C([H])=C7[H])C([H])([H])C5([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C4([H])[H])C3=O |
| EOS-AX4738 | Amisulpride | 71675-85-9 | C17H27N3O4S | 369.48 | CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC |
| EOS-AX4739 | Chlorpromazine HCl | 69-09-0 | C17H19ClN2S.HCl | 355.33 | CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl |
| EOS-AX4740 | Domperidone | 57808-66-9 | C22H24ClN5O2 | 425.91 | C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O |
| EOS-AX4741 | Dopamine HCl | 62-31-7 | C8H11NO2.HCl | 189.64 | C1=CC(=C(C=C1CCN)O)O.Cl |
| EOS-AX4742 | Fenoldopam | 67227-56-9 | C16H16ClNO3 | 305.76 | C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O |
| EOS-AX4743 | Levosulpiride | 23672-07-3 | C15H23N3O4S | 341.43 | CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC |
| EOS-AX4744 | Pergolide mesylate | 66104-23-2 | C19H26N2S.CH4O3S | 410.59 | CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O |
| EOS-AX4745 | Amantadine HCl | 665-66-7 | C10H17N.HCl | 187.7 | C1C2CC3CC1CC(C2)(C3)N.Cl |
| EOS-AX4746 | Pramipexole 2HCl Monohydrate | 191217-81-9 | C10H17N3S.2HCl.H2O | 302.26 | CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl |
| EOS-AX4747 | Pramipexole | 104632-26-0 | C10H17N3S | 211.33 | CCCNC1CCC2=C(C1)SC(=N2)N |
| EOS-AX4748 | Benserazide HCl | 14919-77-8 | C10H15N3O5.HCl | 293.7 | C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl |
| EOS-AX4749 | Quetiapine Fumarate | 111974-72-2 | C46H54N6O8S2 | 883.09 | C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O |
| EOS-AX4750 | PD128907 HCl | 112960-16-4 | C14H19NO3.HCl | 285.77 | CCCN1CCOC2C1COC3=C2C=C(C=C3)O.Cl |
| EOS-AX4751 | PYR-41 | 418805-02-4 | C17H13N3O7 | 371.3 | CCOC(=O)C1=CC=C(C=C1)N2C(=O)C(=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N2 |
| EOS-AX4752 | AG-490 (Tyrphostin B42) | 133550-30-8 | C17H14N2O3 | 294.3 | C1=CC=C(C=C1)CNC(=O)C(=CC2=CC(=C(C=C2)O)O)C#N |
| EOS-AX4753 | Tyrphostin 9 | 10537-47-0 | C18H22N2O | 282.38 | CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C=C(C#N)C#N |
| EOS-AX4754 | OSI-420 | 183320-51-6 | C21H22ClN3O4 | 415.87 | COCCOC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCO.Cl |
| EOS-AX4755 | Icotinib | 610798-31-7 | C22H21N3O4 | 391.42 | [H]C1=C2OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC2=C([H])C3=NC([H])=NC(N([H])C4=C([H])C([H])=C([H])C(C#C[H])=C4[H])=C31 |
| EOS-AX4756 | I-BET-762 | 1260907-17-2 | C22H22ClN5O2 | 423.9 | CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C |
| EOS-AX4757 | RVX-208 | 1044870-39-4 | C20H22N2O5 | 370.4 | CC1=CC(=CC(=C1OCCO)C)C2=NC(=O)C3=C(C=C(C=C3N2)OC)OC |
| EOS-AX4758 | I-BET151 (GSK1210151A) | 1300031-49-5 | C23H21N5O3 | 415.44 | CC1=C(C(=NO1)C)C2=C(C=C3C(=C2)N=CC4=C3N(C(=O)N4)C(C)C5=CC=CC=N5)OC |
| EOS-AX4759 | Estradiol Cypionate | 313-06-4 | C26H36O3 | 396.56 | CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O |
| EOS-AX4760 | Ethisterone | 434-03-7 | C21H28O2 | 312.45 | CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C#C)O)C |
| EOS-AX4761 | Altrenogest | 850-52-2 | C21H26O2 | 310.43 | CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O |
| EOS-AX4762 | Clomiphene citrate | 50-41-9 | C26H28ClNO.C6H8O7 | 598.08 | CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4763 | Epiandrosterone | 481-29-8 | C19H30O2 | 290.44 | CC12CCC(CC1CCC3C2CCC4(C3CCC4=O)C)O |
| EOS-AX4764 | Estradiol valerate | 979-32-8 | C23H32O3 | 356.5 | CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C |
| EOS-AX4765 | Estriol | 50-27-1 | C18H24O3 | 288.39 | CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O |
| EOS-AX4766 | Ethynodiol diacetate | 297-76-7 | C24H32O4 | 384.51 | CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C |
| EOS-AX4767 | Hexestrol | 84-16-2 | C18H22O2 | 270.37 | CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O |
| EOS-AX4768 | Medroxyprogesterone acetate | 71-58-9 | C24H34O4 | 386.52 | CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C |
| EOS-AX4769 | Mifepristone | 84371-65-3 | C29H35NO2 | 429.59 | CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O |
| EOS-AX4770 | Pregnenolone | 145-13-1 | C21H32O2 | 316.48 | CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| EOS-AX4771 | Toremifene Citrate | 89778-27-8 | C32H36ClNO8 | 598.08 | CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4772 | Equol | 531-95-3 | C15H14O3 | 242.27 | C1C(COC2=C1C=CC(=C2)O)C3=CC=C(C=C3)O |
| EOS-AX4773 | Raloxifene HCl | 82640-04-8 | C28H28ClNO4S | 510.04 | C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl |
| EOS-AX4774 | Dienogest | 65928-58-7 | C20H25NO2 | 311.42 | CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O |
| EOS-AX4775 | Gestodene | 60282-87-3 | C21H26O2 | 310.43 | CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34 |
| EOS-AX4776 | Erteberel (LY500307) | 533884-09-2 | C18H18O3 | 282.33 | C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O |
| EOS-AX4777 | Bazedoxifene HCl | 198480-56-7 | C30H34N2O3.HCl | 507.06 | CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.Cl |
| EOS-AX4778 | Drospirenone | 67392-87-4 | C24H30O3 | 366.49 | O=C1OC2(C([H])([H])C1([H])[H])C3([H])C(C3([H])[H])([H])C4([H])C2(C([H])([H])[H])C([H])([H])C([H])([H])C(C(C([H])([H])C5([H])[H])(C([H])([H])[H])C6=C([H])C5=O)([H])C4([H])C7([H])C6([H])C7([H])[H] |
| EOS-AX4779 | Bosentan Hydrate | 157212-55-0 | C27H31N5O7S | 569.63 | CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O |
| EOS-AX4780 | Sitaxentan sodium | 210421-74-2 | C18H14ClN2NaO6S2 | 476.89 | CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)[N-]C4=C(C(=NO4)C)Cl)OCO2.[Na+] |
| EOS-AX4781 | PF-573228 | 869288-64-2 | C22H20F3N5O3S | 491.49 | CS(=O)(=O)C1=CC=CC(=C1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)CC4 |
| EOS-AX4782 | Erastin | 571203-78-6 | C30H31ClN4O4 | 547.04 | CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl |
| EOS-AX4783 | SSR128129E | 848318-25-2 | C18H15N2O4.Na | 346.31 | CC1=C(N2C=CC=CC2=C1OC)C(=O)C3=CC(=C(C=C3)N)C(=O)[O-].[Na+] |
| EOS-AX4784 | Tandutinib (MLN518) | 387867-13-2 | C31H42N6O4 | 562.72 | CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5 |
| EOS-AX4785 | GW4064 | 278779-30-9 | C28H22Cl3NO4 | 542.85 | CC(C)C1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)COC3=CC(=C(C=C3)C=CC4=CC(=CC=C4)C(=O)O)Cl |
| EOS-AX4786 | XL335 | 629664-81-9 | C25H24F2N2O3 | 438.48 | CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F |
| EOS-AX4787 | Gabapentin HCl | 60142-95-2 | C9H18ClNO2 | 207.7 | C1CCC(CC1)(CC(=O)O)CN.Cl |
| EOS-AX4788 | Niflumic acid | 4394-00-7 | C13H9F3N2O2 | 282.22 | C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F |
| EOS-AX4789 | (R)-baclofen | 69308-37-8 | C10H12ClNO2 | 213.66 | C1=CC(=CC=C1C(CC(=O)O)CN)Cl |
| EOS-AX4790 | Nefiracetam | 77191-36-7 | C14H18N2O2 | 246.3 | CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O |
| EOS-AX4791 | BMS-378806 | 357263-13-9 | C22H22N4O4 | 406.43 | CC1CN(CCN1C(=O)C(=O)C2=CNC3=NC=CC(=C23)OC)C(=O)C4=CC=CC=C4 |
| EOS-AX4792 | AZD1981 | 802904-66-1 | C19H17ClN2O3S | 388.87 | CC1=C(C2=C(N1CC(=O)O)C=CC=C2NC(=O)C)SC3=CC=C(C=C3)Cl |
| EOS-AX4793 | OC000459 | 851723-84-7;950688-14-9(sodium salt) | C21H17FN2O2 | 348.37 | CC1=C(C2=C(N1CC(=O)O)C=CC(=C2)F)CC3=NC4=CC=CC=C4C=C3 |
| EOS-AX4794 | AZD1080 | 612487-72-6 | C19H18N4O2 | 334.37 | C1COCCN1CC2=CNC(=C3C4=C(C=CC(=C4)C#N)NC3=O)C=C2 |
| EOS-AX4795 | AZD2858 | 486424-20-8 | C21H23N7O3S | 453.52 | NC1=C(C(NC2=CC=CN=C2)=O)N=C(C3=CC=C(S(=O)(N4CCN(C)CC4)=O)C=C3)C=N1 |
| EOS-AX4796 | GSK-3 Inhibitor IX (BIO) | 667463-62-9 | C16H10BrN3O2 | 356.17 | C1=CC2=C(C(=C3C4=C(C=C(C=C4)Br)NC3=O)N=C2C=C1)NO |
| EOS-AX4797 | Tideglusib | 865854-05-3 | C19H14N2O2S | 334.39 | C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43 |
| EOS-AX4798 | TWS119 | 601514-19-6 | C18H14N4O2 | 318.33 | C1=CC(=CC(=C1)N)C2=CC3=C(N2)N=CN=C3OC4=CC=CC(=C4)O |
| EOS-AX4799 | Mubritinib (TAK 165) | 366017-09-6 | C25H23F3N4O2 | 468.47 | C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F |
| EOS-AX4800 | Tyrphostin AG 879 | 148741-30-4 | C18H24N2OS | 316.46 | CC(C)(C)C1=CC(=CC(=C(N)S)C#N)C=C(C1=O)C(C)(C)C |
| EOS-AX4801 | Brompheniramine hydrogen maleate | 980-71-2 | C16H19BrN2.C4H4O4 | 435.31 | CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O |
| EOS-AX4802 | Buclizine HCl | 129-74-8 | C28H33ClN2.2HCl | 505.95 | CC(C)(C)C1=CC=C(C=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl |
| EOS-AX4803 | Cetirizine DiHCl | 83881-52-1 | C21H27Cl3N2O3 | 461.81 | C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl |
| EOS-AX4804 | Cyclizine 2HCl | 5897-18-7 | C18H22N2.2HCl | 339.3 | CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl |
| EOS-AX4805 | Hydroxyzine 2HCl | 2192-20-3 | C21H27ClN2O2.2HCl | 447.83 | C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl |
| EOS-AX4806 | Levodropropizine | 99291-25-5 | C13H20N2O2 | 236.31 | C1CN(CCN1CC(CO)O)C2=CC=CC=C2 |
| EOS-AX4807 | Mizolastine | 108612-45-9 | C24H25FN6O | 432.49 | CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5 |
| EOS-AX4808 | Nizatidine | 76963-41-2 | C12H21N5O2S2 | 331.46 | CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C |
| EOS-AX4809 | Tripelennamine HCl | 154-69-8 | C16H22ClN3 | 291.82 | CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl |
| EOS-AX4810 | Benztropine mesylate | 132-17-2 | C21H25NO.CH4SO3 | 403.53 | CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O |
| EOS-AX4811 | Betahistine 2HCl | 5579-84-0 | C8H12N2.2HCl | 209.12 | CNCCC1=CC=CC=N1.Cl.Cl |
| EOS-AX4812 | Chlorpheniramine Maleate | 113-92-8 | C16H19ClN2.C4H4O4 | 390.86 | CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O |
| EOS-AX4813 | Cimetidine | 51481-61-9 | C10H16N6S | 252.34 | CC1=C(N=CN1)CSCCNC(=NC)NC#N |
| EOS-AX4814 | Clemastine Fumarate | 14976-57-9 | C21H26ClNO.C4H4O4 | 459.96 | CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O |
| EOS-AX4815 | Cyproheptadine HCl | | | | |
| EOS-AX4816 | Famotidine | 76824-35-6 | C8H15N7O2S3 | 337.45 | C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N |
| EOS-AX4817 | Histamine 2HCl | 56-92-8 | C5H9N3.2HCl | 184.07 | C1=C(NC=N1)CCN.Cl.Cl |
| EOS-AX4818 | Ketotifen Fumarate | 34580-14-8 | C23H23NO5S | 425.5 | CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)O)C(=O)O |
| EOS-AX4819 | Pemirolast potassium | 100299-08-9 | C10H7N6O.K | 266.3 | CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+] |
| EOS-AX4820 | Ranitidine | 66357-59-3 | C13H22N4O3S.HCl | 350.86 | CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl |
| EOS-AX4821 | Roxatidine Acetate HCl | 93793-83-0 | C19H28N2O4.HCl | 384.9 | CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2.Cl |
| EOS-AX4822 | Rupatadine Fumarate | 182349-12-8 | C26H26ClN3.C4H4O4 | 532.03 | CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.C(=CC(=O)O)C(=O)O |
| EOS-AX4823 | Azatadine dimaleate | 3978-86-7 | C28H30N2O8 | 522.55 | CN1CCC(=C2C3=CC=CC=C3CCC4=C2N=CC=C4)CC1.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O |
| EOS-AX4824 | Azelastine HCl | 79307-93-0 | C22H24ClN3O.HCl | 418.36 | CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl |
| EOS-AX4825 | Bepotastine Besilate | 190786-44-8 | C27H31ClN2O6S | 547.06 | C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O |
| EOS-AX4826 | Ciproxifan | 184025-18-1 | C16H18N2O2 | 270.33 | C1CC1C(=O)C2=CC=C(C=C2)OCCCC3=CN=CN3 |
| EOS-AX4827 | Desloratadine | 100643-71-8 | C19H19ClN2 | 310.82 | C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4 |
| EOS-AX4828 | Latrepirdine | 97657-92-6 | C21H25N3.2HCl | 392.37 | CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl |
| EOS-AX4829 | Fexofenadine HCl | 153439-40-8 | C32H39NO4.HCl | 538.12 | CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl |
| EOS-AX4830 | JNJ-7777120 | 459168-41-3 | C14H16ClN3O | 277.75 | CN1CCN(CC1)C(=O)C2=CC3=C(N2)C=CC(=C3)Cl |
| EOS-AX4831 | Lafutidine | 118288-08-7 | C22H29N3O4S | 431.55 | C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3 |
| EOS-AX4832 | Olopatadine HCl | 140462-76-6 | C21H23NO3.HCl | 373.87 | CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl |
| EOS-AX4833 | C646 | 328968-36-1 | C24H19N3O6 | 445.42 | CC1=C(C=C(C(=C1)C2=CC=C(O2)C=C3C(=NN(C3=O)C4=CC=C(C=C4)C(=O)O)C)[N+](=O)[O-])C |
| EOS-AX4834 | Tranylcypromine (2-PCPA) HCl | 4548-34-9 | C9H11N.HCl | 169.65 | C1C(C1N)C2=CC=CC=C2.Cl |
| EOS-AX4835 | JIB-04 | 199596-05-9 | C17H13ClN4 | 308.76 | C1=CC=C(C=C1)C(=NNC2=NC=C(C=C2)Cl)C3=CC=CC=N3 |
| EOS-AX4836 | OG-L002 | 1357302-64-7 | C15H15NO | 225.29 | C1C(C1N)C2=CC=C(C=C2)C3=CC(=CC=C3)O |
| EOS-AX4837 | EPZ004777 HCl | 1380316-03-9 | C28H41N7O4.HCl | 576.13 | CC(C)N(CCCNC(=O)NC1=CC=C(C=C1)C(C)(C)C)CC2C(C(C(O2)N3C=CC4=C3N=CN=C4N)O)O.Cl |
| EOS-AX4838 | MM-102 | 1417329-24-8 | C35H49F2N7O4 | 669.8 | CCC(CC)(C(=O)NC(CCCN=C(N)N)C(=O)NC1(CCCC1)C(=O)NC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)NC(=O)C(C)C |
| EOS-AX4839 | UNC1999 | 1431612-23-5 | C33H43N7O2 | 569.74 | CCCC1=C(C(=O)NC(=C1)C)CNC(=O)C2=C3C=NN(C3=CC(=C2)C4=CN=C(C=C4)N5CCN(CC5)C(C)C)C(C)C |
| EOS-AX4840 | NVP-ADW742 | 475488-23-4 | C28H31N5O | 453.58 | C1CCN(C1)CC2CC(C2)N3C=C(C4=C3N=CN=C4N)C5=CC(=CC=C5)OCC6=CC=CC=C6 |
| EOS-AX4841 | SC-514 | 354812-17-2 | C9H8N2OS2 | 224.3 | C1=CSC=C1C2=CC(=C(S2)C(=O)N)N |
| EOS-AX4842 | IKK-16 (IKK Inhibitor VII) | 873225-46-8 | C28H29N5OS | 483.63 | C1CCN(C1)C2CCN(CC2)C(=O)C3=CC=C(C=C3)NC4=NC=CC(=N4)C5=CC6=CC=CC=C6S5 |
| EOS-AX4843 | IMD 0354 | 978-62-1 | C15H8ClF6NO2 | 383.67 | C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O |
| EOS-AX4844 | Dexamethasone Sodium Phosphate | 55203-24-2 | C22H30FO8P.2Na | 516.4 | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+] |
| EOS-AX4845 | Pacritinib (SB1518) | 937272-79-2 | C28H32N4O3 | 472.58 | [H]C1([H])N(C([H])([H])C([H])([H])OC(C([H])=C2[H])=C(C([H])([H])OC([H])([H])/C([H])=C([H])\C([H])([H])OC([H])([H])C3=C([H])C4=C([H])C([H])=C3[H])C([H])=C2N([H])C5=NC([H])=C([H])C4=N5)C([H])([H])C([H])([H])C1([H])[H] |
| EOS-AX4846 | SB743921 | 940929-33-9 | C31H34Cl2N2O3 | 553.53 | CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=C(C(=O)C3=C(O2)C=C(C=C3)Cl)CC4=CC=CC=C4)C(C)C.Cl |
| EOS-AX4847 | Ki16198 | 355025-13-7 | C24H25ClN2O5S | 488.98 | CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2Cl)C3=CC=C(C=C3)CSCCC(=O)OC |
| EOS-AX4848 | Hexamethonium Bromide | 55-97-0 | C12H30N2.2Br | 362.19 | C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-] |
| EOS-AX4849 | Irsogladine | 57381-26-7 | C9H7Cl2N5 | 256.09 | C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl |
| EOS-AX4850 | Neostigmine Bromide | 114-80-7 | C12H19N2O2.Br | 303.2 | CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-] |
| EOS-AX4851 | Succinylcholine Chloride Dihydrate | 6101-15-1 | C14H30N2O4.2Cl.2H2O | 397.34 | C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-] |
| EOS-AX4852 | Acetylcholine Chloride | 60-31-1 | C7H16NO2.Cl | 181.66 | CC(=O)OCC[N+](C)(C)C.[Cl-] |
| EOS-AX4853 | Arecoline | 300-08-3 | C8H13NO2.HBr | 236.11 | CN1CCC=C(C1)C(=O)OC.Br |
| EOS-AX4854 | Biperiden HCl | 1235-82-1 | C21H30ClNO | 347.92 | C1CCN(CC1)CCC(C2CC3CC2C=C3)(C4=CC=CC=C4)O.Cl |
| EOS-AX4855 | Bethanechol chloride | 590-63-6 | C7H17N2O2.Cl | 196.68 | CC(C[N+](C)(C)C)OC(=O)N.[Cl-] |
| EOS-AX4856 | Darifenacin HBr | 133099-07-7 | C28H31BrN2O2 | 507.48 | C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br |
| EOS-AX4857 | Decamethonium Bromide | 541-22-0 | C16H38N2.2Br | 418.29 | C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-] |
| EOS-AX4858 | Donepezil HCl | 120011-70-3 | C24H30ClNO3 | 415.95 | COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl |
| EOS-AX4859 | Homatropine Bromide | 51-56-9 | C16H21NO3.HBr | 356.25 | CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br |
| EOS-AX4860 | Homatropine Methylbromide | 80-49-9 | C17H24NO3.Br | 370.28 | C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-] |
| EOS-AX4861 | Hyoscyamine | 101-31-5 | C17H23NO3 | 289.37 | CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 |
| EOS-AX4862 | Orphenadrine Citrate | 4682-36-4 | C18H23NO.C6H8O7 | 461.5 | CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4863 | Otilonium Bromide | 26095-59-0 | C29H43BrN2O4 | 563.57 | CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-] |
| EOS-AX4864 | Tropicamide | 1508-75-4 | C17H20N2O2 | 284.35 | CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2 |
| EOS-AX4865 | Aclidinium Bromide | 320345-99-1 | C26H30BrNO4S2 | 564.55 | C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-] |
| EOS-AX4866 | Gallamine Triethiodide | 65-29-2 | C30H60I3N3O3 | 891.53 | CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-] |
| EOS-AX4867 | Methscopolamine | 155-41-9 | C18H24BrNO4 | 398.29 | O=C(C(C1=C([H])C([H])=C([H])C([H])=C1[H])([H])C([H])([H])O[H])O[C@@]2([H])C([H])([H])[C@]3([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C2([H])[H])([H])[C@@]4([H])O[C@@]34[H].[Br-] |
| EOS-AX4868 | Pancuronium dibromide | 15500-66-0 | C35H60N2O4.2Br | 732.67 | CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-] |
| EOS-AX4869 | Pyridostigmine Bromide | 101-26-8 | C9H13BrN2O2 | 261.12 | C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-] |
| EOS-AX4870 | Solifenacin succinate | 242478-38-2 | C27H32N2O6 | 480.55 | C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O |
| EOS-AX4871 | PNU-120596 | 501925-31-1 | C13H14ClN3O4 | 311.73 | CC1=CC(=NO1)NC(=O)NC2=CC(=C(C=C2OC)OC)Cl |
| EOS-AX4872 | Trospium chloride | 10405-02-4 | C25H30NO3.Cl | 427.96 | C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-] |
| EOS-AX4873 | 5-hydroxymethyl Tolterodine (PNU 200577, 5-HMT, 5-HM) | 207679-81-0 | C22H31NO2 | 341.49 | CC(C)N(CCC(C1=CC=CC=C1)C2=C(C=CC(=C2)CO)O)C(C)C |
| EOS-AX4874 | Fesoterodine Fumarate | 286930-03-8 | C30H41NO7 | 527.65 | CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O |
| EOS-AX4875 | Tiotropium Bromide hydrate | 139404-48-1 | C19H22NO4S2.Br.xH2O | 490.43 | O=C(C(C1=C([H])C([H])=C([H])S1)(C2=C([H])C([H])=C([H])S2)O[H])O[C@@]3([H])C([H])([H])[C@]4([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C3([H])[H])([H])[C@@]5([H])O[C@@]45[H].[H]O[H].[Br-] |
| EOS-AX4876 | Tolterodine tartrate | 124937-52-6 | C26H37NO7 | 475.57 | CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4877 | TAK-733 | 1035555-63-5 | C17H15F2IN4O4 | 504.23 | CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O |
| EOS-AX4878 | SGI-1027 | 1020149-73-8 | C27H23N7O | 461.52 | CC1=CC(=NC(=N1)N)NC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)NC4=CC=NC5=CC=CC=C54 |
| EOS-AX4879 | Ifenprodil Tartrate | 23210-58-4 | C21H27NO2.1/2C4H6O6 | 475.53 | CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4880 | NMDA (N-Methyl-D-aspartic acid) | 6384-92-5 | C5H9NO4 | 147.13 | CNC(CC(=O)O)C(=O)O |
| EOS-AX4881 | MK-801 (Dizocilpine) | 77086-21-6 | C16H15N | 221.3 | [H][C@]1(C([H])([H])C2=C([H])C([H])=C([H])C([H])=C32)N([H])[C@]3(C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14 |
| EOS-AX4882 | LY404039 | 635318-11-5 | C7H9NO6S | 235.21 | C1C(C2C(C2S1(=O)=O)C(=O)O)(C(=O)O)N |
| EOS-AX4883 | (-)-MK 801 | 121917-57-5 | C16H15N | 221.3 | C[C@@]1(N2)C3=C(C=CC=C3)C[C@H]2C4=C1C=CC=C4 |
| EOS-AX4884 | MPEP | 96206-92-7 | C14H11N | 193.24 | CC1=CC=CC(=N1)C#CC2=CC=CC=C2 |
| EOS-AX4885 | VU 0357121 | 433967-28-3 | C17H17F2NO2 | 305.32 | CCCCOC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)F)F |
| EOS-AX4886 | VU 0361737 | 1161205-04-4 | C13H11ClN2O2 | 262.69 | COC1=C(C=CC(=C1)NC(=O)C2=CC=CC=N2)Cl |
| EOS-AX4887 | VU 0364770 | 61350-00-3 | C12H9ClN2O | 232.67 | C1=CC=NC(=C1)C(=O)NC2=CC(=CC=C2)Cl |
| EOS-AX4888 | ADX-47273 | 851881-60-2 | C20H17F2N3O2 | 369.36 | C1CC(CN(C1)C(=O)C2=CC=C(C=C2)F)C3=NC(=NO3)C4=CC=C(C=C4)F |
| EOS-AX4889 | CTEP (RO4956371) | 871362-31-1 | C19H13ClF3N3O | 391.77 | CC1=C(N=C(N1C2=CC=C(C=C2)OC(F)(F)F)C)C#CC3=CC(=NC=C3)Cl |
| EOS-AX4890 | Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium | 168555-66-6 | C18H19Na2O8P | 440.29 | COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-].[Na+].[Na+] |
| EOS-AX4891 | CYT997 (Lexibulin) | 917111-44-5 | C24H30N6O2 | 434.53 | CCCC(C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC |
| EOS-AX4892 | Vinflunine Tartrate | 1201898-17-0 | C45H54F2N4O8.xC4H6O6 | 967.02 | [H][C@]12[C@]3(CC)[C@@H](OC(C)=O)[C@](O)(C(OC)=O)[C@]4([H])N(C)C5=CC(OC)=C([C@](C[C@H]6C[C@@H](C(F)(F)C)CN7C6)(C(OC)=O)C8=C(C7)C(C=CC=C9)=C9N8)C=C5[C@@]41CCN2CC=C3.O=C(O)[C@H](O)[C@@H](O)C(O)=O |
| EOS-AX4893 | OSI-027 | 936890-98-1 | C21H22N6O3 | 406.45 | COC1=CC=CC2=CC(=C3C4=C(N=CNN4C(=N3)C5CCC(CC5)C(=O)O)N)N=C21 |
| EOS-AX4894 | WYE-687 | 1062161-90-3 | C28H32N8O3 | 528.61 | COC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCN(CC4)CC5=CN=CC=C5)C(=N2)N6CCOCC6 |
| EOS-AX4895 | Ridaforolimus (Deforolimus, MK-8669) | 572924-54-0 | C53H84NO14P | 990.21 | O=P(C)(C)O[C@H]1[C@H](OC)C[C@H](C[C@@H](C)[C@@H](OC([C@@H]2CCCCN2C(C([C@]3([C@@H](CC[C@@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C([C@H](OC)[C@@H]4O)=O)O3)C)O)=O)=O)=O)CC([C@H](C)/C=C4\C)=O)CC1 |
| EOS-AX4896 | Torin 2 | 1223001-51-1 | C24H15F3N4O | 432.41 | C1=CC(=CC(=C1)N2C(=O)C=CC3=CN=C4C=CC(=CC4=C32)C5=CN=C(C=C5)N)C(F)(F)F |
| EOS-AX4897 | WAY-600 | 1062159-35-6 | C28H30N8O | 494.59 | C1CN(CCC1N2C3=C(C=N2)C(=NC(=N3)C4=CC5=C(C=C4)NC=C5)N6CCOCC6)CC7=CN=CC=C7 |
| EOS-AX4898 | WYE-125132 (WYE-132) | 1144068-46-1 | C27H33N7O4 | 519.61 | CNC(=O)NC1=CC=C(C=C1)C2=NC3=C(C=NN3C4CCC5(CC4)OCCO5)C(=N2)N6CC7CCC(C6)O7 |
| EOS-AX4899 | Sodium 4-Aminosalicylate | 6018-19-5 | C7H7NO3.2H2O.Na | 211.15 | C1=CC(=C(C=C1N)O)C(=O)[O-].O.O.[Na+] |
| EOS-AX4900 | Caffeic Acid Phenethyl Ester | 104594-70-9 | C17H16O4 | 284.31 | C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O |
| EOS-AX4901 | JSH-23 | 749886-87-1 | C16H20N2 | 240.34 | CC1=CC(=C(C=C1)NCCCC2=CC=CC=C2)N |
| EOS-AX4902 | ML130 (Nodinitib-1) | 799264-47-4 | C14H13N3O2S | 287.34 | CC1=CC=C(C=C1)S(=O)(=O)N2C3=CC=CC=C3N=C2N |
| EOS-AX4903 | Naloxone HCl | 357-08-4 | C19H22ClNO4 | 363.84 | |
| EOS-AX4904 | Naltrexone HCl | 16676-29-2 | C20H24ClNO4 | 377.86 | |
| EOS-AX4905 | Racecadotril | 81110-73-8 | C21H23NO4S | 385.48 | CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2 |
| EOS-AX4906 | Trimebutine | 39133-31-8 | C22H29NO5 | 387.47 | CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C |
| EOS-AX4907 | 1-Hexadecanol | 36653-82-4 | C16H34O | 242.44 | CCCCCCCCCCCCCCCCO |
| EOS-AX4908 | 7-Aminocephalosporanic acid | 957-68-6 | C10H12N2O5S | 272.28 | CC(=O)OCC1=C(N2C(C(C2=O)N)SC1)C(=O)O |
| EOS-AX4909 | Alizapride HCl | 59338-87-3 | C16H21N5O2.HCl | 351.83 | COC1=CC2=NNN=C2C=C1C(=O)NCC3CCCN3CC=C.Cl |
| EOS-AX4910 | Aloperine | 56293-29-9 | C15H24N2 | 232.36 | [H][C@@]1([C@]2([H])N([H])C([H])([H])C([H])([H])C([H])([H])C2=C3[H])C([H])([H])[C@@]3([H])[C@](C([H])([H])C([H])([H])C([H])([H])C4([H])[H])([H])N4C1([H])[H] |
| EOS-AX4911 | Alverine Citrate | 5560-59-8 | C20H27N.C6H8O7 | 473.56 | CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O |
| EOS-AX4912 | Amfenac Sodium Monohydrate | 61618-27-7 | C15H12NO3.H2O.Na | 295.27 | C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)[O-])N.O.[Na+] |
| EOS-AX4913 | Amikacin hydrate | 1257517-67-1 | C22H43N5O13.xH2O | 585.6+x18 | C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.O |
| EOS-AX4914 | Amikacin disulfate | 39831-55-5 | C22H43N5O13.2H2O4S | 781.76 | C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O |
| EOS-AX4915 | Aminothiazole | 96-50-4 | C3H4N2S | 100.14 | C1=CSC(=N1)N |
| EOS-AX4916 | Amoxapine | 14028-44-5 | C17H16ClN3O | 313.78 | C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl |
| EOS-AX4917 | Amoxicillin | 26787-78-0 | C16H19N3O5S | 365.4 | CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C |
| EOS-AX4918 | Ampicillin Trihydrate | 7177-48-2 | C16H19N3O4S.3H2O | 403.45 | CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O |
| EOS-AX4919 | Amprolium HCl | 137-88-2 | C14H19N4.HCl.Cl | 315.24 | CCCC1=NC=C(C(=N1)N)C[N+]2=CC=CC=C2C.Cl.[Cl-] |
| EOS-AX4920 | Antazoline HCl | 2508-72-7 | C17H19N3.HCl | 301.81 | C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl |
| EOS-AX4921 | Apramycin Sulfate | 65710-07-8 | C21H41N5O11.xH2O4S | 637.66 | CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O |
| EOS-AX4922 | Atracurium Besylate | 64228-81-5 | C53H72N2O12.2(C6H5O3S) | 1243.48 | C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-] |
| EOS-AX4923 | Azaguanine-8 | 134-58-7 | C4H4N6O | 152.11 | C12=NNNC1=NC(=NC2=O)N |
| EOS-AX4924 | Azaperone | 1649-18-9 | C19H22FN3O | 327.4 | C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3 |
| EOS-AX4925 | Azithromycin Dihydrate | 117772-70-0 | C38H72N2O12.2H2O | 785.02 | CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O |
| EOS-AX4926 | Bacitracin | 1405-87-4 | C65H101N17O16S | 1408.67 | CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4 |
| EOS-AX4927 | Bacitracin Zinc | 1405-89-6 | C66H101N17O16SZn | 1486.06 | CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)CC)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3C=NC=N3)CC4=CC=CC=C4.[Zn] |
| EOS-AX4928 | Bemegride | 64-65-3 | C8H13NO2 | 155.19 | CCC1(CC(=O)NC(=O)C1)C |
| EOS-AX4929 | Benzbromarone | 3562-84-3 | C17H12Br2O3 | 424.08 | CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br |
| EOS-AX4930 | Benzethonium Chloride | 121-54-0 | C27H42NO2.Cl | 448.08 | CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-] |
| EOS-AX4931 | Benzocaine | 94-09-7 | C9H11NO2 | 165.19 | CCOC(=O)C1=CC=C(C=C1)N |
| EOS-AX4932 | Benzoic Acid | 65-85-0 | C7H6O2 | 122.12 | C1=CC=C(C=C1)C(=O)O |
| EOS-AX4933 | Benzydamine HCl | 132-69-4 | C19H23N3O.HCl | 345.87 | CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl |
| EOS-AX4934 | Penicillin G Sodium | 69-57-8 | C16H18N2O4S.Na | 356.37 | CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+] |
| EOS-AX4935 | Betamipron | 3440-28-6 | C10H11NO3 | 193.2 | C1=CC=C(C=C1)C(=O)NCCC(=O)O |
| EOS-AX4936 | Bezafibrate | 41859-67-0 | C19H20ClNO4 | 361.82 | CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl |
| EOS-AX4937 | Bismuth Subcitrate Potassium | 880149-29-1 | C12H10BiK5O14+2 | 782.67 | C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[K+].[K+].[K+].[K+].[K+].[Bi+3] |
| EOS-AX4938 | Bosentan | 147536-97-8 | C27H29N5O6S | 551.63 | CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC |
| EOS-AX4939 | Brimonidine Tartrate | 70359-46-5 | C15H16BrN5O6 | 442.22 | C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O |
| EOS-AX4940 | Bromfenac Sodium | 91714-93-1 | C15H11BrNO3.Na | 356.15 | C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+] |
| EOS-AX4941 | Broxyquinoline | 521-74-4 | C9H5Br2NO | 302.95 | C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1 |
| EOS-AX4942 | Bucladesine Sodium Salt | | | | |
| EOS-AX4943 | Buspirone HCl | 33386-08-2 | C21H31N5O2.HCl | 421.96 | C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl |
| EOS-AX4944 | Calcium Levofolinate | 80433-71-2 | C20H21N7O7.Ca | 511.5 | C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Ca+2] |
| EOS-AX4945 | Capreomycin Sulfate | 1405-37-4 | C25H44N14O7.H2SO4 | 750.78 | O=C([C@]([H])(C)NC([C@](N)([H])CNC1=O)=O)N[C@@]([H])(CNC(CC(CCCN)N)=O)C(NC(C(N[C@@]1([H])[C@@H]2CCNC(N)=N2)=O)=CNC(N)=O)=O.[xH2SO4] |
| EOS-AX4946 | Carprofen | 53716-49-7 | C15 H12ClNO2 | 273.71 | CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O |
| EOS-AX4947 | Ceftriaxone Sodium Trihydrate | 104376-79-6 | C18H16N8O7S3.7/2H2O.2Na | 661.6 | O=C1N(C(C([O-])=O)=C2CSC(N(C)N=C3[O-])=NC3=O)[C@H](SC2)[C@@H]1NC(/C(C4=CSC(N)=N4)=N\OC)=O.[Na+].[Na+].[3.5H2O] |
| EOS-AX4948 | Cephalexin | 15686-71-2 | C16H17N3O4S | 347.39 | CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O |
| EOS-AX4949 | Cetrimonium Bromide (CTAB) | 57-09-0 | C19H42N.Br | 364.45 | CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-] |
| EOS-AX4950 | Cetylpyridinium Chloride | 123-03-5 | C21H38N.Cl | 339.99 | CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-] |
| EOS-AX4951 | Chlorhexidine HCl | 3697-42-5 | C22H30Cl2N10.2HCl | 578.37 | C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl |
| EOS-AX4952 | Chlorocresol | 59-50-7 | C7H7ClO | 142.58 | CC1=C(C=CC(=C1)O)Cl |
| EOS-AX4953 | Chlorpropamide | 94-20-2 | C10H13ClN2O3S | 276.74 | CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl |
| EOS-AX4954 | Chlorquinaldol | 72-80-0 | C10H7Cl2NO | 228.07 | CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl |
| EOS-AX4955 | Chlortetracycline HCl | 64-72-2 | C22H23ClN2O8.HCl | 515.34 | CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl |
| EOS-AX4956 | Chlorthalidone | 77-36-1 | C14H11ClN2O4S | 338.77 | C1=CC=C2C(=C1)C(=O)NC2(C3=CC(=C(C=C3)Cl)S(=O)(=O)N)O |
| EOS-AX4957 | Chlorzoxazone | 95-25-0 | C7H4ClNO2 | 169.57 | C1=CC2=C(C=C1Cl)NC(=O)O2 |
| EOS-AX4958 | Cholesterol | 57-88-5 | C27H46O | 386.65 | CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C |
| EOS-AX4959 | Choline Chloride | 67-48-1 | C5H14NO.Cl | 139.62 | C[N+](C)(C)CCO.[Cl-] |
| EOS-AX4960 | Chromocarb | 4940-39-0 | C10H6O4 | 190.15 | C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O |
| EOS-AX4961 | Cinchophen | 132-60-5 | C16H11NO2 | 249.26 | C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O |
| EOS-AX4962 | Climbazole | 38083-17-9 | C15H17ClN2O2 | 292.76 | CC(C)(C)C(=O)C(N1C=CN=C1)OC2=CC=C(C=C2)Cl |
